Jill S. Halterman

Dr. Jill S. Halterman is a distinguished physician-scientist who serves as the Chair of Pediatrics and Physician-in-Chief for Golisano Children's Hospital at the University of Rochester Medical Center. She is also a Professor in the Department of Pediatrics, General Pediatrics, and holds the William H. Eilinger Chair of Pediatrics. Dr. Halterman is board certified in Pediatrics by the American Board of Pediatrics and provides clinical care in the pediatric primary care practice.

Dr. Halterman completed her medical education at the University of Rochester School of Medicine/Dentistry, earning her MD in 1994. She furthered her education with an MPH from the University of Rochester School of Medicine/Dentistry in 2001. Her clinical training includes internships and residencies at Children's Hospital of Philadelphia and Strong Memorial Hospital/University of Rochester Medical Center from 1994-1998.

Dr. Halterman is a clinical investigator who leads a research program designed to understand the multifactorial contributions driving asthma disparities and to improve care for historically marginalized children with this disease. Her work focuses on developing and implementing community-based interventions to improve asthma care and reduce morbidity, with a particular emphasis on health equity. She has pioneered school-based asthma management programs that have been replicated in numerous communities across the country. Her research integrates clinical care, community partnerships, and policy advocacy to create sustainable systems of asthma care that reach children where they are. She has led multiple large randomized trials in community settings and primary care offices to improve asthma care and reduce morbidity, receiving continuous NIH funding for over twenty years.

Dr. Halterman's extensive publication record reflects her commitment to advancing pediatric asthma care through innovative approaches including telemedicine, school-based interventions, and community health partnerships. Her work spans clinical trials, health services research, and implementation science, with a consistent focus on reducing health disparities and improving outcomes for vulnerable children. Recent research has explored the integration of technology in asthma management, the impact of social determinants on asthma outcomes, and strategies to improve medication adherence in diverse pediatric populations.

• Academic Pediatric Association: Miller Sarkin Mentoring Award - Research (2024)
• Presidential Stronger as One Diversity Award (2024)
• Rochester Business Journal Health Care Heroes: 2020 Physician Award (2020)
• Samuel Rosenthal Prize of Excellence in Academic Pediatrics (2019)
• Dr. David Satcher Community Health Improvement Award (2019)
• Election into American Pediatric Society (2013)
• Robert Wood Johnson Generalist Faculty Physician Scholars Award (2002)

Dr. Halterman has received continuous NIH funding for over twenty years, securing more than $28 million in extramural funding for her research. She has mentored numerous trainees across the academic pipeline and served as principal investigator for multiple large randomized trials in community settings and primary care offices. Her work has been instrumental in developing evidence-based approaches to asthma management that have been cited in national asthma guidelines and guidelines for school health. She is deeply committed to training the next generation of physician-scientists focused on health equity and community-based research.

Dr. Halterman leads research initiatives that collaborate with community partners, schools, and healthcare systems to develop and test innovative approaches to improving asthma care for marginalized children. Her work integrates clinical research with community engagement to create sustainable interventions that address the complex factors contributing to asthma disparities, including the School-Based Telemedicine Enhanced Asthma Management (SB-TEAM) program and the Telehealth Education for Asthma Connecting Hospital and Home (TEACHH) pilot study.